Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova, Anthony G. Phillips
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 929-942
Closed Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Michael P. Bogenschutz, Stephen Ross, Snehal Bhatt, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 10, pp. 953-953
Open Access | Times Cited: 414
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 173
The neural basis of psychedelic action
Alex C. Kwan, David E. Olson, Katrin H. Preller, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 11, pp. 1407-1419
Closed Access | Times Cited: 166
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 106
Default Mode Network Modulation by Psychedelics: A Systematic Review
James J Gattuso, Daniel Perkins, Simon Ruffell, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 26, Iss. 3, pp. 155-188
Open Access | Times Cited: 101
Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin
Pasha A. Davoudian, Ling-Xiao Shao, Alex C. Kwan
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 468-480
Open Access | Times Cited: 77
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
Biochemistry (2022) Vol. 61, Iss. 3, pp. 127-136
Open Access | Times Cited: 76
5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines
Lindsay P. Cameron, Seona D. Patel, Maxemiliano V. Vargas, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 351-358
Open Access | Times Cited: 56
Randomized trial of ketamine masked by surgical anesthesia in patients with depression
Theresa R. Lii, Ashleigh E. Smith, Josephine R. Flohr, et al.
Nature Mental Health (2023) Vol. 1, Iss. 11, pp. 876-886
Open Access | Times Cited: 51
Mini-review: The neurobiology of treating substance use disorders with classical psychedelics
Marvin M. Urban, Moritz R. Stingl, Marcus W. Meinhardt
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 40
Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
Yuan Yao, Dan Guo, Tangsheng Lu, et al.
Psychiatry Research (2024) Vol. 335, pp. 115886-115886
Closed Access | Times Cited: 23
Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice
Xiangting Zhao, Yingjie Du, Yishan Yao, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 489-499
Closed Access | Times Cited: 16
Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders
Noemi Nicosia, M. Giovenzana, Paulina Misztak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6521-6521
Open Access | Times Cited: 16
Possible antidepressant mechanisms of omega-3 polyunsaturated fatty acids acting on the central nervous system
Lie Zhou, Jiayao Xiong, Yu-Qian Chai, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 50
The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
Andrea Mastinu, Margrate Anyanwu, Marinella Carone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1329-1329
Open Access | Times Cited: 35
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines
Xiying Fu, Yicun Wang, Fangyi Zhao, et al.
Aging (2023)
Open Access | Times Cited: 30
Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments
John H. Krystal, Alfred P. Kaye, Sarah Jefferson, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 49
Open Access | Times Cited: 30
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
Wenwen Duan, Dongmei Cao, Sheng Wang, et al.
Chemical Reviews (2023) Vol. 124, Iss. 1, pp. 124-163
Closed Access | Times Cited: 30
Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 29
Dopamine pathways mediating affective state transitions after sleep loss
Mingzheng Wu, Xin Zhang, Sihan Feng, et al.
Neuron (2023) Vol. 112, Iss. 1, pp. 141-154.e8
Closed Access | Times Cited: 27
Narrative Review: Low-Dose Ketamine for Pain Management
Alessandro Riccardi, Mario Guarino, Sossio Serra, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3256-3256
Open Access | Times Cited: 25
Randomized Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients
Theresa R. Lii, Ashleigh E. Smith, Josephine R. Flohr, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 22
PI3K-AKT/mTOR Signaling in Psychiatric Disorders: A Valuable Target to Stimulate or Suppress?
Yan Chen, Wei Guan, Meilan Wang, et al.
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 2
Open Access | Times Cited: 14
TrkB transmembrane domain: bridging structural understanding with therapeutic strategy
Giray Enkavi, Mykhailo Girych, Rafael Moliner, et al.
Trends in Biochemical Sciences (2024) Vol. 49, Iss. 5, pp. 445-456
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top